EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+8.64%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.44B
AUM Growth
+$7.44B
(+10%)
Cap. Flow
+$500M
Cap. Flow
% of AUM
6.72%
Top 10 Holdings %
Top 10 Hldgs %
25.63%
Holding
170
New
15
Increased
63
Reduced
24
Closed
16
Top Buys
| 1 |
Zymeworks
ZYME
|
$62.5M |
| 2 |
nCino
NCNO
|
$39.7M |
| 3 |
Shoals Technologies Group
SHLS
|
$37.4M |
| 4 |
Generac Holdings
GNRC
|
$36M |
| 5 |
argenx
ARGX
|
$35.8M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$52M |
| 2 |
Verisk Analytics
VRSK
|
$37M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$25.4M |
| 4 |
Okta
OKTA
|
$23.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
$23.3M |
Sector Composition
| 1 | Healthcare | 35.75% |
| 2 | Technology | 29.25% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 7.52% |
| 5 | Communication Services | 5.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Xenon Pharmaceuticals
XENE
$2.99B
| $27.7M | 0.37% |
1,490,000
| – | – |
|
|
VECT
77
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $26.6M | 0.36% |
+2,341,427
| New | +$26.6M |
|
78
Compass
COMP
$4.76B
| $26.6M | 0.36% |
+2,022,031
| New | +$26.6M |
|
79
Veracyte
VCYT
$2.41B
| $26M | 0.35% |
651,000
| – | – |
|
80
Rollins
ROL
$27.3B
| $24.9M | 0.33% |
727,500
| – | – |
|
81
ALX Oncology
ALXO
$54.6M
| $24.1M | 0.32% |
439,950
+349,950
| +389% | +$19.1M |
|
82
Beyond Meat
BYND
$178M
| $24M | 0.32% |
152,593
| – | – |
|
83
Cardiff Oncology
CRDF
$130M
| $23.8M | 0.32% |
3,575,834
+1,792,346
| +100% | +$11.9M |
|
84
Repligen
RGEN
$6.54B
| $23.8M | 0.32% |
119,000
| – | – |
|
85
Intuitive Surgical
ISRG
$158B
| $23M | 0.31% |
75,000
| – | – |
|
|
86
Neurocrine Biosciences
NBIX
$13.5B
| $22.9M | 0.31% |
235,000
-239,000
| -50% | -$23.3M |
|
87
Agilent Technologies
A
$35.5B
| $22.4M | 0.3% |
151,700
+28,000
| +23% | +$4.14M |
|
88
Tourmaline Bio
TRML
$645M
| $22.4M | 0.3% |
+156,109
| New | +$22.4M |
|
89
Zentalis Pharmaceuticals
ZNTL
$123M
| $22.4M | 0.3% |
420,400
-411,600
| -49% | -$21.9M |
|
90
89bio
ETNB
$1.37B
| $21.3M | 0.29% |
1,137,092
-131,447
| -10% | -$2.46M |
|
91
Sotera Health
SHC
$4.54B
| $21.1M | 0.28% |
870,000
| – | – |
|
|
MRTX
92
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $20.9M | 0.28% |
129,471
| – | – |
|
93
Phathom Pharmaceuticals
PHAT
$843M
| $20.3M | 0.27% |
600,000
| – | – |
|
94
Butterfly Network
BFLY
$378M
| $19.8M | 0.27% |
1,365,000
+247,000
| +22% | +$3.58M |
|
|
FRLN
95
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $19.8M | 0.27% |
165,710
| – | – |
|
|
CCXI
96
DELISTED
ChemoCentryx, Inc.
CCXI
| $18.8M | 0.25% |
1,403,000
+843,000
| +151% | +$11.3M |
|
|
FRC
97
DELISTED
First Republic Bank
FRC
| $18.5M | 0.25% |
98,600
-600
| -0.6% | -$112K |
|
98
Steris
STE
$23.9B
| $18.3M | 0.25% |
88,700
+21,100
| +31% | +$4.35M |
|
99
Keros Therapeutics
KROS
$638M
| $18.2M | 0.24% |
427,414
| – | – |
|
100
nVent Electric
NVT
$14.4B
| $17.5M | 0.24% |
+560,500
| New | +$17.5M |
|